The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses

Overview of attention for article published in Frontiers in Pharmacology, February 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 4 X users

wikipedia: 1 Wikipedia page

Readers on

mendeley: 69 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,806 followers.

RT @dimitar_dr: фармакогенетичното изследване помага да по-ефективно лечение на депресията. The pharmacogenetics of CYP2D6 and CYP2C19 in a…

фармакогенетичното изследване помага да по-ефективно лечение на депресията. The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses https://t.co/1VZPU8o0Zr

Congratulations Kee! Great case series on #2D6 and #2C19 #Pharmacogenetics https://t.co/l1zvShBFYZ

New Research: The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses https://t.co/zYWysrk4QG #pharmacology

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.